TABLE 1.
Strain group and no. | MIC (μg/ml)b |
|||
---|---|---|---|---|
Gentamicin | Ciprofloxacin | Co-trimoxazole | Tetracycline | |
Carbapenem-resistant strains (n = 17)a | ||||
NA084 | >240 | >240 | >240 | 3 |
NA644 | >240 | >240 | >240 | 5 |
NA708 | >240 | 60 | >240 | 3 |
NA086 | >240 | >240 | >240 | 2 |
NA086 T | >240 | 0.01 | 0.05 | 0.1 |
NA099 | >240 | >240 | >240 | 0.1 |
NA099T | 0.01 | 0.1 | 0.01 | 0.01 |
NA316 | >240 | >240 | >240 | 3 |
NA316T | 0.1 | ND | 0.05 | 0.1 |
NA635 | >240 | 120 | >240 | 5 |
NA635T | 24 | ND | >240 | 3 |
NA703 | >240 | >240 | >240 | 0.001 |
NA703T | 16 | ND | 0.05 | 0.001 |
NA724 | >240 | 120 | >240 | 3 |
NA724T | 30 | 0.01 | 0.05 | 0.1 |
NA805 | 60 | 10 | >240 | 0.01 |
NA805T | ND | 1 | 0.05 | 0.01 |
Recipient strain (n = 1) | ||||
K-12 J53 | 0.001 | 0.008 | 0.05 | 0.01 |
Non-ESBL non-carbapenem-resistant strains (n = 10) | ||||
NA433 | 0.1 | 60 | >240 | 10 |
NA010 | 0.1 | 0.008 | 30 | 0.1 |
NA295 | 0.01 | 0.01 | 120 | 0.1 |
NA053 | 0.25 | 1 | >240 | 2 |
NA057 | 0.1 | 30 | >240 | 0.1 |
NA120 | 0.01 | 0.1 | >240 | 0.5 |
NA140 | 0.1 | 0.01 | >240 | 30 |
NA150 | 0.1 | 0.25 | 2 | 0.01 |
NA203 | 0.01 | 0.01 | 0.1 | 0.01 |
NA274 | 0.1 | 10 | >240 | 30 |
The total includes seven meropenem transconjugants (T suffix).
ND, not determined.